We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,598
Reduced
4,167
Closed
928

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRO icon
4951
KRONOS Worldwide
KRO
$989M
$364K ﹤0.01%
25,404
+534
+2% +$8.67K
LGO
4952
Largo
LGO
$70.9M
$363K ﹤0.01%
+23,278
New +$367K
MGF
4953
Aberdeen Government Markets Income Fund
MGF
$92.2M
$363K ﹤0.01%
81,571
+15,268
+23% +$66.7K
SPXS icon
4954
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$332M
$363K ﹤0.01%
1,505
-190
-11% -$50.3K
SYRE icon
4955
Spyre Therapeutics
SYRE
$9.25B
$362K ﹤0.01%
2,083
+84
+4% +$15.3K
HFRO
4956
Highland Opportunities and Income Fund
HFRO
$407M
$361K ﹤0.01%
33,058
+20,295
+159% +$229K
KZR
4957
DELISTED
Kezar Life Sciences
KZR
$361K ﹤0.01%
6,660
+6,159
+1,229% +$350K
PATK icon
4958
Patrick Industries
PATK
$2.85B
$361K ﹤0.01%
7,415
-15,618
-68% -$894K
STEM icon
4959
CALL
Stem
STEM
$52.7M
$360K ﹤0.01%
+500
New +$272K
VICR icon
4960
Vicor
VICR
$10.2B
$359K ﹤0.01%
3,400
-823
-19% -$73.2K
ORMP icon
4961
Oramed Pharmaceuticals
ORMP
$179M
$357K ﹤0.01%
26,681
+24,898
+1,396% +$285K
SYBT icon
4962
Stock Yards Bancorp
SYBT
$2.6B
$357K ﹤0.01%
7,006
-7,865
-53% -$406K
KLRS
4963
Kalaris Therapeutics
KLRS
$96.8M
$357K ﹤0.01%
786
-2,337
-75% -$1.21M
IPOF
4964
PUT
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$357K ﹤0.01%
+35,000
New +$361K
MITK icon
4965
Mitek Systems
MITK
$834M
$356K ﹤0.01%
18,491
-33,334
-64% -$561K
PCG icon
4966
CALL
PG&E
PCG
$38.5B
$356K ﹤0.01%
35,000
-637,100
-95% -$6.84M
BLKB icon
4967
Blackbaud
BLKB
$2.08B
$355K ﹤0.01%
4,642
-829
-15% -$59.8K
EXD
4968
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
$355K ﹤0.01%
30,816
-812
-3% -$9.11K
LDL
4969
DELISTED
Lydall, Inc.
LDL
$354K ﹤0.01%
5,851
-1,716
-23% -$66K
MYGN icon
4970
Myriad Genetics
MYGN
$312M
$353K ﹤0.01%
11,535
-95,989
-89% -$2.77M
ALG icon
4971
Alamo Group
ALG
$2.05B
$352K ﹤0.01%
2,308
-5,964
-72% -$925K
EOSE icon
4972
PUT
Eos Energy Enterprises
EOSE
$1.51B
$352K ﹤0.01%
+19,600
New +$316K
EOCW.U
4973
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$352K ﹤0.01%
+35,200
New +$353K
PINC
4974
DELISTED
Premier
PINC
$350K ﹤0.01%
10,058
-20,849
-67% -$720K
SBI
4975
Western Asset Intermediate Muni Fund
SBI
$108M
$350K ﹤0.01%
35,841
+2,077
+6% +$19.8K

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 928 positions and reducing 4,167 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 928 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.